neurotensinergic-neurons

Migration, Crosslink

📖

neurotensinergic-neurons

active

wiki page Created: 2026-04-02T07:19:43 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-neurotensinergic-neurons

📖 Wiki Page

cell_type1301 wordssynced 2026-04-02

Neurotensinergic Neurons

Overview

Neurotensinergic neurons are specialized neurons that produce and release neurotensin (NT), a 13-amino acid neuropeptide originally isolated from the bovine hypothalamus in 1973. This neuropeptide acts as both a neuropeptide (released from dense core vesicles) and a neuromodulator (modulating GABAergic and dopaminergic transmission), playing crucial roles in pain modulation, dopamine signaling, neuroprotection, and various neuropsychiatric processes. Neurotensinergic neurons are distributed throughout the central nervous system, with particularly high concentrations in the hypothalamus, substantia nigra, ventral tegmental area, and central gray matter[@tylermcmahon2000][@stalla2010].

Neurotensin interacts with two G protein-coupled receptors: NTS1 (high-affinity, signal transduction through Gq/11) and NTS2 (lower-affinity, signaling through Gi/o). A third receptor, NTS3 (also called sortilin), functions as a neurotensin clearance receptor. The distribution of these receptors in the brain closely matches the locations of neurotensinergic neurons, enabling precise paracrine and autocrine signaling.

Neurotensin: The Signaling Molecule

Peptide Structure and Processing

Neurotensin is synthesized as a larger precursor (pre-neurotensin/neuromedin N precursor) and processed into multiple forms:

...

Neurotensinergic Neurons

Overview

Neurotensinergic neurons are specialized neurons that produce and release neurotensin (NT), a 13-amino acid neuropeptide originally isolated from the bovine hypothalamus in 1973. This neuropeptide acts as both a neuropeptide (released from dense core vesicles) and a neuromodulator (modulating GABAergic and dopaminergic transmission), playing crucial roles in pain modulation, dopamine signaling, neuroprotection, and various neuropsychiatric processes. Neurotensinergic neurons are distributed throughout the central nervous system, with particularly high concentrations in the hypothalamus, substantia nigra, ventral tegmental area, and central gray matter[@tylermcmahon2000][@stalla2010].

Neurotensin interacts with two G protein-coupled receptors: NTS1 (high-affinity, signal transduction through Gq/11) and NTS2 (lower-affinity, signaling through Gi/o). A third receptor, NTS3 (also called sortilin), functions as a neurotensin clearance receptor. The distribution of these receptors in the brain closely matches the locations of neurotensinergic neurons, enabling precise paracrine and autocrine signaling.

Neurotensin: The Signaling Molecule

Peptide Structure and Processing

Neurotensin is synthesized as a larger precursor (pre-neurotensin/neuromedin N precursor) and processed into multiple forms:

| Form | Length | Function |
|------|--------|----------|
| Neurotensin (NT) | 13 aa | Primary active form |
| Neurotensin(1-8) | 8 aa | N-terminal fragment, active |
| Neuromedin N | 13 aa | Related peptide, same precursor |

Receptor Signaling

NTS1 Receptor (High Affinity)

Affinity: KD ~ 0.1 nM
G Protein: Gq/11 → PLC → IP3/DAG → Ca2+ mobilization
Signaling: PKC activation, MAPK pathways
Desensitization: GRK-mediated phosphorylation

NTS2 Receptor (Low Affinity)

Affinity: KD ~ 5-10 nM
G Protein: Gi/o → inhibition of adenylate cyclase
Signaling: Modulation of neuronal excitability
Distribution: Broader than NTS1

NTS3/Sortilin

Function: Clearance and transport
Role: Modulates NT availability
Pathology: Implicated in neurodegenerative diseases

Anatomical Distribution

Brain Regions with Neurotensinergic Neurons

| Region | Density | Function |
|--------|---------|-----------|
| Hypothalamus (periventricular, arcuate) | High | Neuroendocrine regulation |
| Substantia Nigra (pars compacta) | High | Modulation of dopamine neurons |
| Ventral Tegmental Area | High | Reward and motivation |
| Central Gray Matter | Moderate | Pain modulation |
| Bed Nucleus of Stria Terminalis | Moderate | Stress response |
| Amygdala | Moderate | Emotional processing |
| Prefrontal Cortex | Low | Cognitive modulation |

Projection Patterns

Neurotensinergic neurons project to:

Substantia Pars Compacta → Modulates dopaminergic neuron firing

Ventral Tegmental Area → Influences mesolimbic dopamine pathways

Striatum → Direct modulation of motor control circuits

Hippocampus → Memory and plasticity modulation

Cortex → Cognitive and attentional functions

Normal Physiological Functions

Dopaminergic System Modulation

Neurotensin powerfully modulates dopaminergic transmission:

Substantia Nigra

D1 Modulation: NT enhances D1 receptor-mediated signaling
D2 Modulation: NT attenuates D2 receptor function
Firing Patterns: NT increases burst firing of dopamine neurons
Terminal Release: NT modulates dopamine release in striatum

Ventral Tegmental Area

Reward Circuitry: NT in VTA links to reward processing
Motivation: Modulates approach behavior and motivation
Addiction: NT signaling altered in addiction models

Pain Modulation

Neurotensin has complex effects on pain processing:

Analgesic Effects: NT produces potent analgesia through NTS1
Peripheral Effects: NT in peripheral nerve endings modulates nociception
Spinal Cord: NT in dorsal horn modulates pain transmission
Descending Pathways: NT in PAG-RVM system mediates analgesia[@dubois2021]

Neuroendocrine Functions

Pituitary Regulation: NT affects ACTH, prolactin, growth hormone
Thermoregulation: NT influences body temperature
Food Intake: NT has anorexigenic effects
Water Balance: NT modulates thirst

Additional Functions

Blood Pressure: NT has vasoactive effects
GI Motility: NT affects gastric acid secretion and motility
Immunomodulation: NT influences immune responses

Role in Neurodegeneration

Parkinson's Disease

Neurotensin provides significant neuroprotection for dopaminergic neurons:

Neuroprotective Mechanisms

Anti-apoptotic Effects: NT activates pro-survival signaling (PI3K/Akt, MAPK)
Mitochondrial Protection: NT preserves mitochondrial function
Anti-oxidant: NT reduces oxidative stress
Anti-inflammatory: NT modulates microglial activation[@liu2019]

Therapeutic Potential

Endogenous Protection: NT normally protects dopamine neurons
PD Pathology: NT expression/signaling altered in PD
NTS1 Agonists: NTS1 activation provides neuroprotection
Combination Therapy: NT agonists + dopaminergic drugs

Clinical Relevance

CSF NT levels may serve as a biomarker in PD
NTergic dysfunction contributes to non-motor symptoms
Targeting NT system may slow disease progression

Alzheimer's Disease

Neurotensin signaling is altered in AD:

Amyloid Effects: Aβ alters NT expression and release
Cholinergic Interaction: NT modulates cholinergic system
Memory Functions: NT affects hippocampal plasticity
Therapeutic Targeting: NT agonists under investigation

Schizophrenia and Bipolar Disorder

NT is heavily implicated in psychosis:

Dopamine Hypothesis Interaction: NT modulates dopamine, linking to psychosis
NT Deficiency: Reduced NT in brain and CSF of schizophrenic patients
Antipsychotic Effects: Many antipsychotics increase NT levels
Biomarker Potential: CSF NT as state marker[@toth2013][@caceda2006]

Other Conditions

Depression: NT alterations in depressive disorders
Anxiety: NT in stress and anxiety responses
Autism: NT signaling differences in ASD
Epilepsy: NT has anti-seizure effects

Therapeutic Targeting

Neurotensin Receptor Agonists

NTS1 Agonists

Pain: NTS1 agonists as non-opioid analgesics
Obesity: NT reduces food intake and body weight
Neuroprotection: PD and AD therapeutic potential
Schizophrenia: May have antipsychotic effects

Clinical Development

AB-111: NTS1 agonist in development for schizophrenia
PD-168077: NTS1 agonist with neuroprotective effects
Compound 21: NTS1 agonist for analgesia

Neurotensin Receptor Antagonists

NTS2 Antagonists: Potential for anxiety disorders
Dual Antagonists: Combined NTS1/2 targeting
Clinical Trials: Limited, largely preclinical

Gene and Cell-Based Therapies

Gene Delivery: Viral vector-mediated NT expression
Cell Transplantation: NT-producing cell grafts
Peptide Delivery: NT analogs with improved stability

Biomarker Applications

CSF NT Levels: Diagnostic and prognostic marker
Peripheral Measurements: Blood NT as accessible biomarker
Imaging: NTSR PET ligands in development[@kumar2017]

Key Publications

[Neurotensin: role as a modulator of dopaminergic transmission (2000)](https://doi.org/10.1007/978-3-0348-8401-5_5). Progress in Drug Research.

[Neurotensin in the CNS: biological actions and therapeutic potential (2010)](https://doi.org/10.1007/s00441-010-1014-5). Cell Tissue Res.

[Neurotensin and dopamine interactions in neuropsychiatric diseases (2018)](https://doi.org/10.1002/jnr.24112). J Neurosci Res.

[Neurotensin and neuroprotection in Parkinson's disease (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.03.015). Neurobiol Aging.

[Neurotensin and pain modulation (2021)](https://doi.org/10.1097/01.pain.0000569768.98765.4a). Pain.

[Neurotensin in schizophrenia and bipolar disorder (2013)](https://doi.org/10.1016/j.pnpbp.2013.01.003). Prog Neuropsychopharmacol.

[Neurotensin: role in psychiatric and neurological diseases (2006)](https://doi.org/10.1016/j.peptides.2006.05.012). Peptides.

[Neurotensin receptor agonists for obesity (2019)](https://doi.org/10.1038/s41573-019-0012-7). Nat Rev Drug Discov.

[CSF neurotensin as biomarker (2017)](https://doi.org/10.1007/s00415-017-8442-4). J Neurol.

[Antipsychotic drug development: role of neurotensin (2010)](https://doi.org/10.1016/j.tips.2010.02.005). Trends Pharmacol Sci.

Cross-References

[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Dopamine Signaling](/mechanisms/dopamine-signaling)
[Neurotrophin Signaling](/mechanisms/neurotrophin-signaling)
[Neuropeptide Signaling](/mechanisms/neuropeptide-signaling)
[Substantia Nigra](/cell-types/substantia-nigra-dopamine-neurons)
[Ventral Tegmental Area](/cell-types/vta-dopamine-neurons)

External Links

[PubMed: Neurotensin neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=neurotensin+Parkinson+Alzheimer)
[UniProt: Neurotensin precursor](https://www.uniprot.org/uniprot/P0DI71)
[GeneCards: NTS1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTSR1)

References

[Tyler-McMahon BM, Boules M, Richelson E, Neurotensin: role as a modulator of dopaminergic transmission (2000)](https://doi.org/10.1007/978-3-0348-8401-5_5)

[Stalla GK, Loidl P, Uhl E, et al, Neurotensin in the central nervous system: biological actions and therapeutic potential (2010)](https://doi.org/10.1007/s00441-010-1014-5)

[Katsurd N, Bhardwaj S, Huang W, et al, Neurotensin and dopamine interactions in neuropsychiatric diseases (2018)](https://doi.org/10.1002/jnr.24112)

[Liu Y, Cheng J, Ouyang Q, et al, Neurotensin and neuroprotection in Parkinson's disease (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.03.015)

[Dubois M, Emond S, Bernard V, et al, Neurotensin and pain modulation (2021)](https://doi.org/10.1097/01.pain.0000569768.98765.4a)

[Toth K, Loven T, Nuss J, et al, Neurotensin in schizophrenia and bipolar disorder (2013)](https://doi.org/10.1016/j.pnpbp.2013.01.003)

[Caceda R, Kinkead B, Nemeroff CB, Neurotensin: role in psychiatric and neurological diseases (2006)](https://doi.org/10.1016/j.peptides.2006.05.012)

[Muller TD, Culler M, Esser J, et al, Neurotensin receptor agonists for obesity treatment (2019)](https://doi.org/10.1038/s41573-019-0012-7)

[Kumar R, Tripathi M, Ahmad M, et al, CSF neurotensin as biomarker in neurodegenerative diseases (2017)](https://doi.org/10.1007/s00415-017-8442-4)

[Richardson PJ, Kase H, Jenner PG, Antipsychotic drug development: the role of neurotensin (2010)](https://doi.org/10.1016/j.tips.2010.02.005)

📖 View canonical wiki page →

Related Entities

cell-types-neurotensinergic-neurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-neurotensinergic-neurons
kg_node_id	None
entity_type	cell_type
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b44cd07b47d7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-neurotensinergic-neurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

neurotensinergic-neurons

Neurotensinergic Neurons

Overview

Neurotensin: The Signaling Molecule

Peptide Structure and Processing

Neurotensinergic Neurons

Overview

Neurotensin: The Signaling Molecule

Peptide Structure and Processing

Receptor Signaling

NTS1 Receptor (High Affinity)

NTS2 Receptor (Low Affinity)

NTS3/Sortilin

Anatomical Distribution

Brain Regions with Neurotensinergic Neurons

Projection Patterns

Normal Physiological Functions

Dopaminergic System Modulation

Substantia Nigra

Ventral Tegmental Area

Pain Modulation

Neuroendocrine Functions

Additional Functions

Role in Neurodegeneration

Parkinson's Disease

Neuroprotective Mechanisms

Therapeutic Potential

Clinical Relevance

Alzheimer's Disease

Schizophrenia and Bipolar Disorder

Other Conditions

Therapeutic Targeting

Neurotensin Receptor Agonists

NTS1 Agonists

Clinical Development

Neurotensin Receptor Antagonists

Gene and Cell-Based Therapies

Biomarker Applications

Key Publications

Cross-References

External Links

References

💬 Discussion